Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents

Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents

Background The choice of optimal drug‐eluting stent therapy for patients with diabetes mellitus (DM) undergoing percutaneous coronary intervention remains uncertain. We aimed to assess the long‐term clinical outcomes after percutaneous coronary intervention with biodegradable polymer sirolimus‐eluti...

Full description

Bibliographic Details
Main Authors: Juan F. Iglesias, Dik Heg, Marco Roffi, David Tüller, Jonas Lanz, Fabio Rigamonti, Olivier Muller, Igal Moarof, Stéphane Cook, Daniel Weilenmann, Christoph Kaiser, Florim Cuculi, Marco Valgimigli, Peter Jüni, Stephan Windecker, Thomas Pilgrim
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
biodegradable polymer
diabetes mellitus
drug‐eluting stent
long‐term outcomes
ultrathin stent strut
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.013607

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.119.013607

Similar Items